Lv1
60 积分 2023-04-04 加入
BCMA-Targeted T-Cell Engager for Autoimmune Hemolytic Anemia after CD19 CAR T-Cell Therapy
13天前
已完结
Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR × LGR5 bispecific antibody with efficacy in epithelial tumors
1个月前
已完结
Myeloid cell-targeted therapies for solid tumours
1个月前
已完结
New immune cell engagers for cancer immunotherapy
1个月前
已完结
IBI112, a selective anti-IL23p19 monoclonal antibody, displays high efficacy in IL-23-induced psoriasiform dermatitis
1个月前
已完结
Pharmacology, pharmacokinetics, and toxicity characterization of a novel anti-CD73 therapeutic antibody IBI325 for cancer immunotherapy
2个月前
已完结
Immunotherapy combinations overcome resistance to bispecific T cell engager treatment in T cell–cold solid tumors
3个月前
已完结
Humanization of T cell–mediated immunity in mice
3个月前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
3个月前
已完结
Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab
4个月前
已关闭
皖公网安备34019202002308
